List of Tables
Table 1. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Fusion Protein Anti-VEGF Ophthalmic Drugs Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Fusion Protein Anti-VEGF Ophthalmic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Fusion Protein Anti-VEGF Ophthalmic Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Fusion Protein Anti-VEGF Ophthalmic Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Fusion Protein Anti-VEGF Ophthalmic Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Fusion Protein Anti-VEGF Ophthalmic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fusion Protein Anti-VEGF Ophthalmic Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Region (2019-2024) & (K Dose)
Table 18. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Region (2025-2030) & (K Dose)
Table 20. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Country (2019-2024) & (K Dose)
Table 27. North America Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Country (2025-2030) & (K Dose)
Table 28. North America Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Fusion Protein Anti-VEGF Ophthalmic Drugs Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales (K Dose) by Type (2019-2024)
Table 51. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales (K Dose) by Type (2025-2030)
Table 52. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Price (US$/Dose) by Type (2019-2024)
Table 59. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Price (US$/Dose) by Type (2025-2030)
Table 60. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales (K Dose) by Application (2019-2024)
Table 61. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales (K Dose) by Application (2025-2030)
Table 62. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Price (US$/Dose) by Application (2019-2024)
Table 69. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Price (US$/Dose) by Application (2025-2030)
Table 70. Regeneron Pharmaceuticals Company Information
Table 71. Regeneron Pharmaceuticals Description and Business Overview
Table 72. Regeneron Pharmaceuticals Fusion Protein Anti-VEGF Ophthalmic Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Regeneron Pharmaceuticals Fusion Protein Anti-VEGF Ophthalmic Drugs Product
Table 74. Regeneron Pharmaceuticals Recent Developments/Updates
Table 75. Samsung Bioepis Company Information
Table 76. Samsung Bioepis Description and Business Overview
Table 77. Samsung Bioepis Fusion Protein Anti-VEGF Ophthalmic Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Samsung Bioepis Fusion Protein Anti-VEGF Ophthalmic Drugs Product
Table 79. Samsung Bioepis Recent Developments/Updates
Table 80. Biocon Biologics Company Information
Table 81. Biocon Biologics Description and Business Overview
Table 82. Biocon Biologics Fusion Protein Anti-VEGF Ophthalmic Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Biocon Biologics Fusion Protein Anti-VEGF Ophthalmic Drugs Product
Table 84. Biocon Biologics Recent Developments/Updates
Table 85. Chengdu Kanghong Pharmaceutical Company Information
Table 86. Chengdu Kanghong Pharmaceutical Description and Business Overview
Table 87. Chengdu Kanghong Pharmaceutical Fusion Protein Anti-VEGF Ophthalmic Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Chengdu Kanghong Pharmaceutical Fusion Protein Anti-VEGF Ophthalmic Drugs Product
Table 89. Chengdu Kanghong Pharmaceutical Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Fusion Protein Anti-VEGF Ophthalmic Drugs Distributors List
Table 93. Fusion Protein Anti-VEGF Ophthalmic Drugs Customers List
Table 94. Fusion Protein Anti-VEGF Ophthalmic Drugs Market Trends
Table 95. Fusion Protein Anti-VEGF Ophthalmic Drugs Market Drivers
Table 96. Fusion Protein Anti-VEGF Ophthalmic Drugs Market Challenges
Table 97. Fusion Protein Anti-VEGF Ophthalmic Drugs Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Fusion Protein Anti-VEGF Ophthalmic Drugs
Figure 2. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Market Share by Type: 2023 & 2030
Figure 4. Aflibercept Product Picture
Figure 5. Conbercept Product Picture
Figure 6. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Market Share by Application: 2023 & 2030
Figure 8. Hospital and Clinic
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Sales (2019-2030) & (K Dose)
Figure 14. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Average Price (US$/Dose) & (2019-2030)
Figure 15. Fusion Protein Anti-VEGF Ophthalmic Drugs Report Years Considered
Figure 16. Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Fusion Protein Anti-VEGF Ophthalmic Drugs Players: Market Share by Revenue in Fusion Protein Anti-VEGF Ophthalmic Drugs in 2023
Figure 19. Fusion Protein Anti-VEGF Ophthalmic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Market Share by Country (2019-2030)
Figure 23. United States Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Country (2019-2030)
Figure 42. Mexico Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Fusion Protein Anti-VEGF Ophthalmic Drugs Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Fusion Protein Anti-VEGF Ophthalmic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Fusion Protein Anti-VEGF Ophthalmic Drugs by Type (2019-2030)
Figure 52. Global Revenue Market Share of Fusion Protein Anti-VEGF Ophthalmic Drugs by Type (2019-2030)
Figure 53. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Price (US$/Dose) by Type (2019-2030)
Figure 54. Global Sales Market Share of Fusion Protein Anti-VEGF Ophthalmic Drugs by Application (2019-2030)
Figure 55. Global Revenue Market Share of Fusion Protein Anti-VEGF Ophthalmic Drugs by Application (2019-2030)
Figure 56. Global Fusion Protein Anti-VEGF Ophthalmic Drugs Price (US$/Dose) by Application (2019-2030)
Figure 57. Fusion Protein Anti-VEGF Ophthalmic Drugs Value Chain
Figure 58. Fusion Protein Anti-VEGF Ophthalmic Drugs Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
